Clinical Trial Update: Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of HBI0101 CAR-T therapy for refractory B-cell autoimmune diseases (SLE, systemic sclerosis, idiopathic inflammatory myopathy, rheumatoid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Inflammatory Myopathy
• Rheumatoid Arthritis
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• HBI0101 CAR-T

Snippet

Sponsor: Polina Stepensky | Conditions: Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc) | Phase 1 | Status: RECRUITING